Your browser doesn't support javascript.
loading
Pulmonary Complications After Allogeneic Hematopoietic Stem Cell Transplantation for Multiple Myeloma: A Case Report.
Szlauer-Stefanska, Anastazja; Krawczyk-Kulis, Malgorzata; Kaminska-Winciorek, Grazyna; Bobek-Billewicz, Barbara; Giebel, Sebastian.
Affiliation
  • Szlauer-Stefanska A; Bone Marrow Transplantation and Oncohematology Department, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland. Electronic address: anastazja.szlauer@io.gliwice.pl.
  • Krawczyk-Kulis M; Bone Marrow Transplantation and Oncohematology Department, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
  • Kaminska-Winciorek G; Bone Marrow Transplantation and Oncohematology Department, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
  • Bobek-Billewicz B; Radiology and Diagnostic Imaging Department, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
  • Giebel S; Bone Marrow Transplantation and Oncohematology Department, Maria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
Transplant Proc ; 52(8): 2551-2553, 2020 Oct.
Article in En | MEDLINE | ID: mdl-32444124
ABSTRACT
We present a case of a young patient with life-threatening pulmonary complications after allogeneic hematopoietic stem cell transplantation (HSCT). The 25-year-old woman, after HSCT for multiple myeloma, developed severe chronic graft-vs-host disease (GvHD), including bronchiolitis obliterans syndrome. During the treatment of chronic GvHD, 18 months after HSCT, she experienced sudden massive pulmonary hemorrhage with cardiac arrest. The computed tomography imaging revealed lesions suggestive of fungal etiology, with cavity adjacent to the pulmonary vessels. Disqualified from invasive treatment due to poor pulmonary performance, she was treated conservatively with broad-spectrum antibiotics and antifungals. The microbiological workup consistently revealed only Pseudomonas aeruginosa colonization. Her condition steadily improved on treatment. Over 18 months after the incident, she did not experience recurrent bleeding nor serious infection, her primary disease remains in remission, and GvHD symptoms are controlled. Allogeneic HSCT offers possibility of sustained immune-mediated disease control and sometimes even cure, but despite reduced transplant related mortality, GvHD and infections may be detrimental for transplant recipients. Our report illustrates atypical manifestation of pulmonary lesions and highlights the importance of infection control during GvHD treatment.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchiolitis Obliterans / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Multiple Myeloma Limits: Adult / Female / Humans Language: En Journal: Transplant Proc Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Bronchiolitis Obliterans / Hematopoietic Stem Cell Transplantation / Graft vs Host Disease / Multiple Myeloma Limits: Adult / Female / Humans Language: En Journal: Transplant Proc Year: 2020 Document type: Article